is an adhesion-class of G protein-coupled receptor with an unknown function in development. Here, we show that Xenopus laevis lphn2 (Xlphn2) is involved in the migration and differentiation of neural crest (NC) cells and placode patterning in Xenopus laevis embryos. Although Xlphn2 mRNA was detected throughout embryogenesis, it was expressed more abundantly in the placode region. Morpholino antisense oligonucleotide-mediated knockdown of Xlphn2 caused abnormal migration of NC cells, irregular epibranchial placode segmentation, and defective cartilage formation. Transplantation of fluorescently-labeled NC regions of wild-type embryos into Xlphn2 morpholino-injected embryos reproduced the defective NC cell migration, indicating that Xlphn2 regulates the migration of NC cells in a non-cell autonomous manner. Our results suggest that Xlphn2 is essential for placode patterning and as a guidance molecule for NC cells.
Introduction
Neural crest (NC) cells are multipotent stem cells that give rise to a variety of cell lineages including melanocytes, craniofacial cartilage and bone, smooth muscle, and peripheral and enteric neurons and glia (Huang and Saint-Jeannet, 2004) . Cranial NC cells are highly motile and migrate along branchial arches (Kulesa et al., 2010) . During NC cell migration, placode precursors chemoattract NC cells that locomote collectively (Steventon et al., 2014; Theveneau et al., 2010) . Conversely, repulsion of placode precursors by NC cells, which is similar to contact inhibition, prevents the intermingling of NC cells and placode-derived cells (Steventon et al., 2014; Theveneau et al., 2013) . The interaction between NC cells and placodal cells specifies a subdivision of NC cells in the branchial arches (Steventon et al., 2014) . Impairment of NC cell migration is a causative factor for craniofacial birth defects including cleft lip, cleft palate, and the malformation of facial structures (Marcucio et al., 2015) . Understanding the mechanism of NC cell migration is important for understanding the etiology of these craniofacial diseases.
The adhesion-class of G protein-coupled receptors, which includes the latrophilin family of proteins (LPHN1, LPHN2, and LPHN3), have a C-terminal seven-transmembrane domain and a large N-terminal extracellular domain that are implicated in cell-cell and extracellular matrix interactions (Langenhan et al., 2013) . Human LPHN1 is involved in evoked exocytosis of neurotransmitters induced by spider venom (Capogna et al., 2003; Deak et al., 2009) . As endogenous ligands for LPHN1 and LPHN3, Lasso (a splice variant of teneurin-2) and fibronectin leucine-rich repeat transmembrane proteins were identified, respectively (Silva et al., 2011; O'Sullivan et al., 2012) . It is of note that an LPHN3 variant has been linked statistically with the onset of attention-deficit/hyperactivity disorder (Arcos-Burgos et al., 2010) . Knockout of Lphn2 in the hippocampal CA1 region of mice affected spatial memory retention, suggesting that Lphn2 regulates synaptic function (Anderson et al., 2017) .
Results

Identification and expression of Xlphn2 gene
Three latrophilin-family genes have been identified in mouse and human. We searched for frog orthologs of LPHN1-3 in the Xenopus laevis genome database and identified Xlphn1 on chromosome 3S/L, Xlphn2 on chromosome 4S/L, and Xlphn3 on chromosome 1S (Fig. S1 ). Xlphn2 gene analysis showed that Xlphn2 protein contains a galactose binding lectin domain, an olfactomedin-like domain, a G-protein-coupled receptor proteolytic site, and a seven transmembrane receptor domain, which are conserved among Latrophilins and are highly identical to their vertebrate orthologs (Fig. S2 ). The expression of Xlphn2 mRNA was detected in the fertilized embryo to tadpole stages, whereas Xlphn1 was expressed after stage 25 (Fig. 1A) . The expression of Xlphn3 was not detected until stage 35 (data not shown). Whole mount in situ hybridization (WISH) analysis also revealed that Xlphn2 was expressed ubiquitously in the fertilized embryo to the early neurula stage. At stage 23, we noticed that Xlphn2 mRNA was expressed more abundantly in placodes, neural tissue, and pronephric primodia (Fig. 1B) . This locally concentrated expression of Xlphn2 continued to stage 30 in the epibranchial placodes, pronephros, midbrain, and rhombomere region (Fig. 1C ). As a negative control, sense probe for Xlphn2 revealed no expression in this experimental setting ( Fig. 1D, E) .
Xlphn2 morphants show a reduced head structure with cartilage defects
Based on the Xenopus laevis genomic DNA sequence, we designed an Xlphn2-specific morpholino antisense oligonucleotide (MO) to disrupt functionally two Xlphn2 genes on chromosome 4S and 4L. This Xlphn2 MO suppressed fluorescence produced by enhanced green fluorescent protein (EGFP) mRNA fused with the 5'UTR of Xlphn2, but not by that of EGFP alone ( Fig. S3 ). Injection of control MO did not affect embryonic development ( Fig. 2A) . By contrast, the Xlphn2 MO-injected embryos exhibited a reduced head structure, mild suppression of eye development, and a bend in the anterior-posterior axis at stage 35 ( Fig. 2B ). These phenotypes were reversed to normal morphology (as shown in the uninjected control) by co-injection with human LPHN2-FLAG mRNA (Fig. 2C , D). In situ hybridization using probes for the neural marker N-CAM showed that the expression of N-CAM was not affected by Xlphn2 MO except for slightly diminished staining in the eye region ( Fig. 2 E,F). Quantitative reverse-transcription PCR (qRT-PCR) revealed that N-CAM expression was unchanged at stage 30 whereas the expression of a lens marker, β-crystallin, was suppressed ( Fig.  S4 ). Since lens structure was derived from placode (Schlosser, 2006) , the injection of Xlphn2 MO may induce the defects in the lens placode. In NC-derived tissues, pigmented cells were reduced slightly in developing Xlphn2 MO-injected embryos until stage 40 (Fig. 2 G, H) . Alcian blue staining also indicated that the cranial cartilage derived from NC was diminished at tadpole stage in the Xlphn2 MO-injected embryo compared to the control MO-injected embryo ( Fig. 2 I,J) . Especially, branchial cartilage was more severely affected than meckel's or ceratohyal cartilage ( Fig. 2 I,J) .
Xlphn2 is required for the migration and proper distribution of neural crest cells
We examined the expression of NC markers in Xlphn2 MOinjected embryos. The expression pattern of the pan-NC marker Xtwist (Hopwood et al., 1989 , Lander et al., 2013 was not altered at stage 15 in the Xlphn2 morphant, suggesting that Xlphn2 is not required for the induction of NC cells ( Fig. S 5 A,B ). Xtwist staining also revealed that the migration of NC cells was reduced in the Xlphn2 MO-injected embryos at stage 23 compared with the control MO-injected embryos ( Fig. 3 A,B ). However, by stage 30, Xtwist-positive NC cells had migrated into branchial arches in both control and Xlphn2 MO-injected embryos ( Fig. 3 C,D) . In the control MO-injected embryo, four Xtwist-positive segments appeared along branchial arches ( Fig. 3C, arrowhead) , consistent Lphn2 in neural crest migration 33
with the results of a previous report (Lander et al., 2013) . In the Xlphn2 MO-injected embryo, the third arch became wider and overlapped with the region of the fourth arch (Fig. 3D, arrowhead) . qRT-PCR analysis showed that the expression levels of neural crest markers, Xtwist and Xsox10, were not affected by injection of Xlphn2 MO (Fig. S4 ). Next, we examined the expression of Xdlx-2, which marks migratory and post-migratory craniofacial NC cells (Square et al., 2015) . The staining pattern of Xdlx-2 confirmed that the third and fourth branchial arches were not separated, even at stage 23, in the Xlphn2 MO-injected embryos compared with the control MO-injected embryos (Fig. 3 E,F, arrowhead) . At stage 30, the Xdlx-2-positive region covered the third and fourth branchial arches in the Xlphn2 MO-injected embryo (Fig. 3 G,H) . These results suggest that Xlphn2 regulates the migration and proper distribution of cranial NC cells.
Malformation of the epibrachial placode was associated with fusion of branchial neural crest
Since a reciprocal interaction between NC and placodal cells is required for normal morphogenesis of these populations, we examined placode development in the Xlphn2 morphant. The expression of the specific placode marker Xfoxi4.1 (Schlosser and Ahrens, 2004) showed that the placodal cell population appeared normal at the neurula stage in the control MO and Xlphn2 MO-injected embryos ( Fig. 4 A,B ). However, in the Xl-phn2 MO-injected tailbud-stage embryo, one of the epibranchial placode segment was disrupted ( Fig. 4 C,D) . qRT-PCR analysis of placode markers, Xsix1 and Xfoxi4.1, showed that Xlphn2 MO injection had no effect on Xsix1 expression but slightly increased the expression of Xfoxi4.1 (Fig. S4) . These results reflected the broader expression pattern of Xfox4.1 in the anterior epibranchial placodes of Xlphn2 MO-injected embryo (Fig. 4D) , and supported the conclusion that placodes were fused rather than lost. Double staining for NC cells and placodal cells indicated that the fusion of branchial arches was caused by loss of the epibranchial placode ( Fig. 4 E-H) . Thus, Xlphn2 mRNA concentrated in the placode plays an important function in placode formation.
Xlphn2 is essential for neural crest migration in a non-cellautonomous manner
To examine whether Xlphn2 is required for the migration capability of NC cells or serves as environmental cue for NC cell migration, we performed transplantation experiments. First, we investigated the migration pattern of tdTomato (tdTom)-labeled NC cells excised from tdTom-injected embryos after transplantation into the control MO-injected embryos (Fig. 5 A-C, M) . The transplanted tdTom-labeled NC cells migrated ventrally along the distinct streams in the control MO-injected embryos (17/22 embryos). By contrast, tdTom-labeled NC cells did not reach the branchial arches in Xlphn2 MO-injected host (20/22 embryos) ( Fig. 5 D-F, M) . On the other hand, when we transplanted tdTomlabeled NC cells from embryos which were co-injected with tdTom mRNA and control MO or Xlphn2 MO, were transplanted into the wild-type host, they migrated normally to the branchial arches (control MO 8/11, Xlphn2 MO 9/12 embryos) ( Fig. 5 G-L, M) . These results suggested that Xlphn2 was not required for the migration capacity of NC cells. Rather, these results demonstrate that Xlphn2 is involved in the guidance of NC cells in a non-cellautonomous fashion.
Discussion
Knockout of Lphn2 in mice is embryonic lethal, implying fundamental functions of Lphn2 in embryonic development. In this study, we found that Xlphn2 is required for the proper migration and distribution of NC cells in the branchial arches. In the Xlphn2 morphant, NC cells were localized abnormally and the third and fourth NC streams in the branchial arches were fused. Xlphn2defective NC cells migrated in the normal embryos, while normal NC cells did not move in the Xlphn2-defective embryo. These results suggest that Xlphn2 in the placode is important for the migration of NC cells. Branchial arches provide survival and environmental signals for differentiation of cranial cartilage when NC cells reach these regions (Szabo-Rogers et al., 2010) . NC cells in the Xlphn2 morphant, which migrate slowly, may not receive sufficient survival signals during migration, leading to cranial cartilage defects. It is also possible that separation of third and fourth branchial arch NCs by placodes was required for normal growth of cartilage structure since branchial cartilage, which originated from them, was most severely affected in Xlphn2 morphant.
Mayor and colleagues reported that placodes provide chemoattractant(s) and contact inhibition factor(s) for NC cells (Steventon et al., 2014 , Theveneau et al., 2010 , Theveneau et al., 2013 . These factors are essential for correct NC cell migration and segmentation of placodes. In agreement, ablation of NC cells abolished the formation of epibranchial structure (Theveneau et al., 2010) . Our NC cell transplantation data suggests that Xlphn2 is required for the migration of NC cells as an environmental factor. Similarly, the Ephrin signaling pathway has been implicated in the guidance of NC cells. The dominant negative form of EphA2 disrupts the separation of NC cells in the third and fourth arches (Helbling et al., 1998) . This phenotype is very similar to that of the Xlphn2 MO-injected embryos. Since the expression level of EphA2 was not changed in the Xlphn2 MO-injected embryo (data not shown), EphA2 is not considered a downstream regulator of Xlphn2.
Adhesion-class G protein-coupled receptors are important for cell-cell interactions and associations with the extracellular matrix (Langenhan et al., 2013) . LPHN1-, 2-, or 3-expressing cells bind to cells expressing Teneurin2 or 4 (Boucard et al., 2014) , indicating that latrophilin family proteins are involved in cell adhesion. We could not detect the expression of Teneurin2 and 4 in NC cells or placodes during NC cell migration stages (data not shown). Therefore, there may be other ligand molecules for Xlphn2. The exploration of Xlphn2 binding protein(s) expressed in NC cells is critical for fully understanding the mechanism of action of Lphn2.
Materials and Methods
Embryos
Eggs were obtained by injecting human chorionic gonadotropin (Gestron: Denka Seiyaku, Japan) into female Xenopus laevis. Fertilized eggs were obtained by artificial insemination and dejellied using 2% L-cystein hydrochloride (WAKO, Osaka, Japan). Embryos were staged as described previously (Nieukoop and Faber 1956) .
Molecular cloning of human and Xenopus Lphn2
Xlphn2 cDNA fragment was amplified by PCR using cDNA from stage 35 embryos as a template, and was cloned into pGEM-T vector. Primer sets for amplifying Xlphn2 fragments were 5'-actagtgtataccctctgcc-3' and 5'-accagccaaatctgctccta-3'. Sequence was identical to the deposited data for chromosome 4S. Human LPHN2 cDNA was cloned by RT-PCR using cDNA of human monocytic leukemia cell line, THP-1 as a template. FLAG sequence was added to the C-terminal end of LPHN2 and cloned into pCS2 + vector.
RT-PCR
RT-PCR was performed as described previously (Tanegashima et al., 2004) . Total RNA was reverse-transcribed using PrimeScript RT reagent kits (Takara, Otsu, Japan). qRT-PCR was carried out using Thunderbird SYBR qPCR Mix (Toyobo, Osaka, Japan) and a LightCycler480 system (Roche Applied Science, Indianapolis, IN). Messenger RNA expression levels were determined using the relative quantification method (LightCy-cler480 software, Roche Applied Science) and EF1a as a reference gene. The primer sequences are listed in Table S1 .
Microinjection
Two-cell Xenopus embryos were injected with 5 nl of capped RNA and/ or MO in each of the animal blastomeres. The embryos were cultured in 0.1 X Steinberg's solution. MOs were synthesized by Gene Tools (Gene Tools LLC, Philomath, USA). The sequence of Xlphn2 MO was 5'-CCTGCTGC-CAGGAGTCACCATTATT-3' (designed for translation initiation site). Gene Tool control MO (5'-CCTCTTACCTCAGTTACAATTTATA-3') was used as a negative control. Synthetic RNA was made using mMessage mMachine SP6 (Thermo Fisher, Waltham, USA). NotI-linearized pCS2 + human LPHN2-FLAG, pCS2 + tdTomato, pCS2 + EGFP, and pCS2 + Xlphn2 5'UTR-EGFP were used as templates. Injection experiments were done more than twice for phenotype analyses and WISH.
Alcian blue staining
Embryos were fixed overnight in 100% ethanol at stage 45, and stained with 0.01% Alcian blue (WAKO) in 20% acetic acid/EtOH for 3 days. After rehydration, samples were refixed in 4% paraformaldehyde (WAKO). Fixed embryos were treated with 2% KOH followed by several rinses to clear the cartilage structure. Head skin was removed to mount onto glass slides and photographed.
WISH
WISH was performed according to Harland (1991) using Xlphn2, N-CAM, Xtwist, Xdlx-2, and Xfoxi4.1 as probes. pGEMT-Xlphn2 was linearized by SpeI and transcribed by T7 polymerase to produce Digoxigenin (DIG)-UTP (Roche Applied Science, Penzberg, Germany)-labeled antisense probe, and by NcoI to produce sense probe. pBluescript-N-CAM, and Xtwist were linearized by EcoRI, pBluescript-Xdlx-2 were linearized by SpeI. The linearized plasmids were transcribed by T7 polymerase (Takara, Otsu, Japan) to produce DIG-labeled antisense probe. pBluescript-Xfox4.1., which was kindly provided by Dr. Sei Kuriyama (Akita University), was linearized by PstI and transcribed by T3 polymerase (Takara) to produce DIG-labeled antisense probe. DIG-labled probes were detected by BM purple AP substrate (Roche Applied Science). For double staining, fluorescein-UTP (Roche Applied Science)-labeled Xtwist and DIG-labeled Xfox4.1 probes were hybridized. The DIG-labeled probe was detected by BM purple AP substrate (purple) and the fluorescein-labeled probe was detected by 5-bromo-4-chloro-3'indolyphosphate (BCIP, Roche Applied Sciences: light blue).
Transplantation
Control MO (40 ng) + tdTom mRNA (100 pg), X1phn2 MO (40 ng) + tdTom mRNA (100 pg) or tdTom mRNA (100 pg) were used for microinjection at animal pole of 2-cell embryos. tdTom-labeled NC cells were dissected at stage 20, and transplanted to the right side of presumptive otic vesicle region of stage 20 embryo (wild-type, 40 ng Ctl MO-injected, or 40 ng Xlphn2 MO-injected embryos). After fixation at stage 30, fluorescent imaging and morphology were photographed using a Leica M165 FC microscope (Leica, Wetzlar, Germany). Five independent experiments were carried out. The percentages of migrated NCs in different experiments are shown as means with standard error (Fig. 5M ). Statistical analyses against samples of control MO-injected host transplanted with tdTom-injected NC cells were performed using Fisher's exact t-test using the total number of transplanted embryos.
